ARTICLES ON VALVULOPATHIES
Percutaneous mitral repair vs. surgery in secondary mitral regurgitation
Analysis of the MATTERHORN trial on the efficacy and safety of two therapeutic approaches for treating secondary mitral regurgitation in patients with heart failure and optimal medical therapy: transcatheter edge-to-edge repair and mitral valve surgery (repair or replacement).
Aortic Stenosis and Stable Coronary Artery Disease: What Should We Address First? TAVI-PCI Study
Analysis of evidence on the optimal timing for performing percutaneous coronary intervention (PCI) in TAVI candidates, along with an outline of the TAVI-PCI study protocol.
Melody prosthesis: Is it an effective alternative as a bridge to mechanical valve replacement in young children?
Updated results on the Melody bovine jugular vein bioprosthesis as a strategy to gain time before definitive prosthetic valve replacement in pediatric patients with non-repairable mitral regurgitation.
The management of secondary mitral regurgitation. A paradigm shift
This commentary addresses a comprehensive review on the current management of secondary mitral regurgitation (sMR).
Mitral valve replacement in children: five-year outcomes from the HALO trial
This prospective, multicenter, single-arm clinical trial evaluates the efficacy and safety of the 15-mm St. Jude Medical Masters HP® mechanical mitral valve over five years in pediatric patients under five years of age.
Degenerative mitral regurgitation surgery: presentation and outcomes by sex
A retrospective single-center analysis of preoperative status and surgical outcomes in men versus women for all patients undergoing surgery for degenerative mitral regurgitation over 9 years.
Results Following Valve Surgery in Patients with Infective Endocarditis and Preoperative Septic Cerebral Embolism: Insights from the CAMPAIGN Registry
The German CAMPAIGN registry outcomes focused on comparing morbidity and mortality in patients with infective endocarditis (IE) complicated by septic cerebral embolism (SCE) versus those without it.
Mini-Approaches and Sutureless Prostheses… TAVI Is Not the End of Aortic Valve Surgery: Expert Commentary
Commentary by the expert Dr. Elisabet Berastegui on the role of minimally invasive surgery combined with sutureless bioprostheses in the current context.
Reflections on PCI and TAVI in the NOTION 3 Study: The Right to Have Two Diseases, Even in the Heart… and to Have Them Treated
Analysis of the NOTION 3 Study and Its Implications for the Treatment Allocation of Patients with Severe Aortic Stenosis and Concomitant Coronary Artery Disease
When the Aortic Bioprosthesis Degenerates: Revalve or Replace?
This American multicenter retrospective study evaluates the medium-term outcomes of patients with degenerated aortic bioprostheses who underwent either percutaneous valve-in-prosthesis procedures or reoperation for valve replacement.